Drugmakers have raised the list prices of more than 800 prescription drugs — ranging from blood pressure medications to cancer treatments — by a median of 4% at the start of this year, The Wall Street ...

Chief Financial Officer Jess Merten said that the deal will generate a financial book gain of about $450 million and increase deployable capital by $900 million.

The "Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions Training Course" training has been added to ResearchAndMarkets.com's offering. Every biotech product ...